CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

The TGA urged doctors to warn Ozempic users to 'be careful' and check the dose before administering it. Earlier this month, official data revealed more than 100 deaths in the United Kingdom had now ...

Patients have been referred to hospital emergency departments after mistakenly overdosing on diabetes drugs such as Ozempic, ...

Real-time index price for TSX Composite Index (TXCX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Real-time index price for Nasdaq Composite (NASX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

As Warner Music Australia celebrates major representation on the ARIA charts, WMA's President, Records and Publishing, Dan Rosen reflects on the feat.

Ozempic and Wegovy generated combined sales of DKK 50.1 billion in the first quarter of 2025, accounting for around 66% of the company’s total revenues. Novo Nordisk is a global market leader in ...

Wegovy can help you lose a significant amount of weight. So if you have overweight or obesity, the drug can improve your health and quality of life in many ways, outweighing potential long-term risks.

In surprise move Wegovy-maker Novo Nordisk ousts CEO amid sagging sales Days earlier, Novo Nordisk cut its sales and profit forecast for first time since the launch of Wegovy four years ago.

Why you should care: People taking Zepbound, Eli Lilly’s obesity drug, lost almost 50% more weight than individuals using Novo Nordisk’s Wegovy. According to a study funded by Eli Lilly, the ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.